Your browser doesn't support javascript.
loading
Single-cell RNA-Seq reveals the potential risk of anti-mesothelin CAR T Cell therapy toxicity to different organs in humans.
Wen, Lu; Huang, Yu; Peng, Ling; Zhao, Kaiping; Sun, Yan; Lin, Zhicai; Chen, Yuanyuan; Li, Zhong; Qian, Qijun; Tong, Fan; Zhang, Ruiguang; Dong, Xiaorong.
Afiliação
  • Wen L; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Huang Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Peng L; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhao K; Department of Medical Record Management and Statistics, Beijing Jishuitan Hospital, Beijing, China.
  • Sun Y; Shanghai Cell Therapy Group Corporation, Shanghai, China.
  • Lin Z; Shanghai Cell Therapy Group Corporation, Shanghai, China.
  • Chen Y; Shanghai Cell Therapy Group Corporation, Shanghai, China.
  • Li Z; Shanghai Cell Therapy Group Corporation, Shanghai, China.
  • Qian Q; Shanghai Cell Therapy Group Corporation, Shanghai, China.
  • Tong F; Mengchao Cancer Hospital, Shanghai University, Shanghai, China.
  • Zhang R; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Dong X; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Immunol ; 13: 807915, 2022.
Article em En | MEDLINE | ID: mdl-36059490

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article